Gaush Meditech Ltd
HKEX:2407
Net Margin
Gaush Meditech Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
G
|
Gaush Meditech Ltd
HKEX:2407
|
975.1m HKD |
6%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
232.7B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
191.3B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
157.6B USD |
12%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
150.4B USD |
12%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.3B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
51.9B EUR |
9%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
48.8B USD |
7%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.6B USD |
75%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
42.9B USD |
23%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
274.8B CNY |
31%
|
Gaush Meditech Ltd
Glance View
Gaush Meditech Ltd. is an investment holding company, which engages in the provision of ophthalmic medical devices. The company is headquartered in Beijing, Beijing and currently employs 769 full-time employees. The company went IPO on 2022-12-12. The firm operates in four segments. Proprietary Products segment develops and produces surgical equipment and related supporting software, intra optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables. Distribution segment sells brand ophthalmic medical devices and consumables. Technical Services segment provides warranty service, maintenance service and consumables related to after-sales service. Others segment is mainly engaged in equipment leasing business and intellectual property agency services. The firm's products are widely used in the examination, treatment and correction of ophthalmic subspecialty diseases such as fundus disease, cataract, glaucoma, refraction, optometry, ocular surface, and children's ophthalmology.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Gaush Meditech Ltd's most recent financial statements, the company has Net Margin of 6.5%.
You don't have any saved screeners yet